Sign In
Buy RCKT
$3.11
-0.100 (-3.12%)
At Close: Jul 31, 2026
Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
04:04pm, Monday, 06'th Nov 2023
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare
Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals
09:45am, Saturday, 23'rd Sep 2023
Rocket Pharmaceuticals has two programs approaching commercialization. By contrast, Intellia's candidates won't be ready for quite some time.
Here's Why Rocket Pharmaceuticals (RCKT) Rises 53.8% in a Week
12:01pm, Friday, 15'th Sep 2023
Rocket Pharmaceucticals (RCKT) soars 53.8% in a week on news of alignment with the FDA for the mid-stage study of RP-A501, an investigational gene therapy for treating Danon Disease.
Why Is Rocket Pharmaceuticals (RCKT) Stock Up 35% Today?
02:15pm, Wednesday, 13'th Sep 2023
Shares of Rocket Pharmaceuticals (NASDAQ: RCKT ) popped sharply higher on Wednesday, making it one of the top-trending tickers. Yesterday, the biotechnology specialist — which focuses on rare childh
Why Shares of Rocket Pharmaceuticals Are Taking Off on Wednesday
11:56am, Wednesday, 13'th Sep 2023
The company also announced a public stock offering that it said was worth $175 million. The clinical-stage biotech focuses on genetic therapies for rare diseases.
Rocket Pharmaceuticals Stock Jumps Most Since 2020. New Gene Therapy Is Potential 'Value Driver.
10:54am, Wednesday, 13'th Sep 2023
Rocket Pharmaceuticals reaches alignment with the Food and Drug Administration regarding its global Phase 2 trial for a treatment of Danon disease.
Rocket Pharmaceuticals Stock Blasts Off on FDA Buzz
10:52am, Wednesday, 13'th Sep 2023
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock is soaring today, after the biotech name reached an "alignment" with the U.S. Food & Drug Administration (FDA) regarding a mid-stage trial design for its
Rocket Pharmaceuticals stock takes flight on FDA agreement
08:45am, Wednesday, 13'th Sep 2023
Rocket Pharmaceuticals Inc (RCKT) shares surged 32% in pre-market trading on Wednesday after the biotechnology company developing gene therapy announced that it has reached an agreement with the US Fo
Rocket Pharmaceuticals: Thriving Gene Therapy With Multiple Catalysts
12:42am, Thursday, 03'rd Aug 2023
Rocket Pharmaceuticals is developing gene therapies for rare diseases, with positive results and safety profiles from clinical trials. The company's financial performance includes $360 million in cash
3 Small-Cap Stocks You Can't Ignore Now
04:34pm, Monday, 12'th Jun 2023
A small-cap stock is a security whose market capitalization ranges between $250 million and $2 billion. Small-cap stocks are often companies that are relatively small and focused on a niche business.
Rocket (RCKT) Heart Disease Drug Gets Fast Track & Orphan Drug Tag
10:27am, Friday, 09'th Jun 2023
The FDA grants fast track tag and orphan drug designation to Rocket's (RCKT) investigational gene therapy candidate, RP-A601, for cardiac indication. The stock gains 2.3% following the news.
Rocket Pharmaceuticals shares rise on FDA fast-track designation for heart disease treatment
08:25am, Thursday, 08'th Jun 2023
Shares of Rocket Pharmaceuticals RCKT, +0.17% gained 2.3% premarket on Thursday after the late-stage biotech company said the U.S. Food and Drug Administration granted fast-track and orphan-drug desig
Rocket Pharmaceuticals: A Catalyst-Rich Year Ahead
02:34pm, Thursday, 11'th May 2023
Today, we peek back in on Rocket Pharmaceuticals, Inc. for the first time in 2023. The company is seeing some momentum from positive trial developments and new-found enthusiasm from the analyst commun
Rocket Pharmaceuticals: Promising Gene Therapy Play With Discounted Entry Point
12:32pm, Thursday, 16'th Feb 2023
Rocket Pharmaceuticals stock trades at ~$19.5 today - back in December 2021 it had hit highs of >$60. The highs were achieved when Rocket's in vivo gene therapy showed promise treating patients with a
Rocket Pharmaceuticals Has A Lot More Upside
11:09am, Thursday, 16'th Feb 2023
Rocket Pharmaceuticals, Inc. performed beautifully for me in the last half year. They have a number of catalysts in the next few months.
